Ranbaxy Laboratories Ltd has announced the following Unaudited results for the quarter ended September 30, 2009:
The Company has posted a net profit after tax of Rs 1860.81 million for the quarter ended September 30, 2009 as compared to net loss of Rs (3529.30) million for the quarter ended September 30, 2008. Total Income has increased from Rs 12022.15 million for the quarter ended September 30, 2008 to Rs 13651.90 million for the quarter ended September 30, 2009.
Test your strategy and compete with over 150,000 traders online!